Global Leber Congenital Amaurosis (LCA) Market Growth (Status and Outlook) 2022-2028

January 2021 | 86 pages | ID: G9AD7B23D889EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Leber Congenital Amaurosis (LCA) will have significant change from previous year. According to our (LP Information) latest study, the global Leber Congenital Amaurosis (LCA) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Leber Congenital Amaurosis (LCA) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Leber Congenital Amaurosis (LCA) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Leber Congenital Amaurosis (LCA) market, reaching US$ million by the year 2028. As for the Europe Leber Congenital Amaurosis (LCA) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Leber Congenital Amaurosis (LCA) players cover AmpliPhi Biosciences, Editas Medicine, Novelion Therapeutics, and ProQR Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Leber Congenital Amaurosis (LCA) market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Infantile Type
• Juvenile Type

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Hospitals
• Eye Clinics
• Medical Research Institute
• Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• AmpliPhi Biosciences
• Editas Medicine
• Novelion Therapeutics
• ProQR Therapeutics
• Spark Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Leber Congenital Amaurosis (LCA) Market Size 2017-2028
  2.1.2 Leber Congenital Amaurosis (LCA) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Leber Congenital Amaurosis (LCA) Segment by Type
  2.2.1 Infantile Type
  2.2.2 Juvenile Type
2.3 Leber Congenital Amaurosis (LCA) Market Size by Type
  2.3.1 Leber Congenital Amaurosis (LCA) Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2017-2022)
2.4 Leber Congenital Amaurosis (LCA) Segment by Application
  2.4.1 Hospitals
  2.4.2 Eye Clinics
  2.4.3 Medical Research Institute
  2.4.4 Other
2.5 Leber Congenital Amaurosis (LCA) Market Size by Application
  2.5.1 Leber Congenital Amaurosis (LCA) Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2017-2022)

3 LEBER CONGENITAL AMAUROSIS (LCA) MARKET SIZE BY PLAYER

3.1 Leber Congenital Amaurosis (LCA) Market Size Market Share by Players
  3.1.1 Global Leber Congenital Amaurosis (LCA) Revenue by Players (2020-2022)
  3.1.2 Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Players (2020-2022)
3.2 Global Leber Congenital Amaurosis (LCA) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LEBER CONGENITAL AMAUROSIS (LCA) BY REGIONS

4.1 Leber Congenital Amaurosis (LCA) Market Size by Regions (2017-2022)
4.2 Americas Leber Congenital Amaurosis (LCA) Market Size Growth (2017-2022)
4.3 APAC Leber Congenital Amaurosis (LCA) Market Size Growth (2017-2022)
4.4 Europe Leber Congenital Amaurosis (LCA) Market Size Growth (2017-2022)
4.5 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Leber Congenital Amaurosis (LCA) Market Size by Country (2017-2022)
5.2 Americas Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022)
5.3 Americas Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Leber Congenital Amaurosis (LCA) Market Size by Region (2017-2022)
6.2 APAC Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022)
6.3 APAC Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Leber Congenital Amaurosis (LCA) by Country (2017-2022)
7.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022)
7.3 Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Leber Congenital Amaurosis (LCA) by Region (2017-2022)
8.2 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022)
8.3 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LEBER CONGENITAL AMAUROSIS (LCA) MARKET FORECAST

10.1 Global Leber Congenital Amaurosis (LCA) Forecast by Regions (2023-2028)
  10.1.1 Global Leber Congenital Amaurosis (LCA) Forecast by Regions (2023-2028)
  10.1.2 Americas Leber Congenital Amaurosis (LCA) Forecast
  10.1.3 APAC Leber Congenital Amaurosis (LCA) Forecast
  10.1.4 Europe Leber Congenital Amaurosis (LCA) Forecast
  10.1.5 Middle East & Africa Leber Congenital Amaurosis (LCA) Forecast
10.2 Americas Leber Congenital Amaurosis (LCA) Forecast by Country (2023-2028)
  10.2.1 United States Leber Congenital Amaurosis (LCA) Market Forecast
  10.2.2 Canada Leber Congenital Amaurosis (LCA) Market Forecast
  10.2.3 Mexico Leber Congenital Amaurosis (LCA) Market Forecast
  10.2.4 Brazil Leber Congenital Amaurosis (LCA) Market Forecast
10.3 APAC Leber Congenital Amaurosis (LCA) Forecast by Region (2023-2028)
  10.3.1 China Leber Congenital Amaurosis (LCA) Market Forecast
  10.3.2 Japan Leber Congenital Amaurosis (LCA) Market Forecast
  10.3.3 Korea Leber Congenital Amaurosis (LCA) Market Forecast
  10.3.4 Southeast Asia Leber Congenital Amaurosis (LCA) Market Forecast
  10.3.5 India Leber Congenital Amaurosis (LCA) Market Forecast
  10.3.6 Australia Leber Congenital Amaurosis (LCA) Market Forecast
10.4 Europe Leber Congenital Amaurosis (LCA) Forecast by Country (2023-2028)
  10.4.1 Germany Leber Congenital Amaurosis (LCA) Market Forecast
  10.4.2 France Leber Congenital Amaurosis (LCA) Market Forecast
  10.4.3 UK Leber Congenital Amaurosis (LCA) Market Forecast
  10.4.4 Italy Leber Congenital Amaurosis (LCA) Market Forecast
  10.4.5 Russia Leber Congenital Amaurosis (LCA) Market Forecast
10.5 Middle East & Africa Leber Congenital Amaurosis (LCA) Forecast by Region (2023-2028)
  10.5.1 Egypt Leber Congenital Amaurosis (LCA) Market Forecast
  10.5.2 South Africa Leber Congenital Amaurosis (LCA) Market Forecast
  10.5.3 Israel Leber Congenital Amaurosis (LCA) Market Forecast
  10.5.4 Turkey Leber Congenital Amaurosis (LCA) Market Forecast
  10.5.5 GCC Countries Leber Congenital Amaurosis (LCA) Market Forecast
10.6 Global Leber Congenital Amaurosis (LCA) Forecast by Type (2023-2028)
10.7 Global Leber Congenital Amaurosis (LCA) Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 AmpliPhi Biosciences
  11.1.1 AmpliPhi Biosciences Company Information
  11.1.2 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Product Offered
  11.1.3 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 AmpliPhi Biosciences Main Business Overview
  11.1.5 AmpliPhi Biosciences Latest Developments
11.2 Editas Medicine
  11.2.1 Editas Medicine Company Information
  11.2.2 Editas Medicine Leber Congenital Amaurosis (LCA) Product Offered
  11.2.3 Editas Medicine Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Editas Medicine Main Business Overview
  11.2.5 Editas Medicine Latest Developments
11.3 Novelion Therapeutics
  11.3.1 Novelion Therapeutics Company Information
  11.3.2 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
  11.3.3 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Novelion Therapeutics Main Business Overview
  11.3.5 Novelion Therapeutics Latest Developments
11.4 ProQR Therapeutics
  11.4.1 ProQR Therapeutics Company Information
  11.4.2 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
  11.4.3 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 ProQR Therapeutics Main Business Overview
  11.4.5 ProQR Therapeutics Latest Developments
11.5 Spark Therapeutics
  11.5.1 Spark Therapeutics Company Information
  11.5.2 Spark Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
  11.5.3 Spark Therapeutics Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Spark Therapeutics Main Business Overview
  11.5.5 Spark Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Leber Congenital Amaurosis (LCA) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Infantile Type
Table 3. Major Players of Juvenile Type
Table 4. Leber Congenital Amaurosis (LCA) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2017-2022)
Table 7. Leber Congenital Amaurosis (LCA) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2017-2022)
Table 10. Global Leber Congenital Amaurosis (LCA) Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Player (2020-2022)
Table 12. Leber Congenital Amaurosis (LCA) Key Players Head office and Products Offered
Table 13. Leber Congenital Amaurosis (LCA) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Leber Congenital Amaurosis (LCA) Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Regions (2017-2022)
Table 18. Americas Leber Congenital Amaurosis (LCA) Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Leber Congenital Amaurosis (LCA) Market Size Market Share by Country (2017-2022)
Table 20. Americas Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2017-2022)
Table 22. Americas Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2017-2022)
Table 24. APAC Leber Congenital Amaurosis (LCA) Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Region (2017-2022)
Table 26. APAC Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2017-2022)
Table 28. APAC Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2017-2022)
Table 30. Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Country (2017-2022)
Table 32. Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2017-2022)
Table 34. Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Leber Congenital Amaurosis (LCA)
Table 43. Key Market Challenges & Risks of Leber Congenital Amaurosis (LCA)
Table 44. Key Industry Trends of Leber Congenital Amaurosis (LCA)
Table 45. Global Leber Congenital Amaurosis (LCA) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Leber Congenital Amaurosis (LCA) Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Leber Congenital Amaurosis (LCA) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Leber Congenital Amaurosis (LCA) Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Leber Congenital Amaurosis (LCA) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Leber Congenital Amaurosis (LCA) Market Size Market Share Forecast by Application (2023-2028)
Table 51. AmpliPhi Biosciences Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 52. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Product Offered
Table 53. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AmpliPhi Biosciences Main Business
Table 55. AmpliPhi Biosciences Latest Developments
Table 56. Editas Medicine Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 57. Editas Medicine Leber Congenital Amaurosis (LCA) Product Offered
Table 58. Editas Medicine Main Business
Table 59. Editas Medicine Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Editas Medicine Latest Developments
Table 61. Novelion Therapeutics Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 62. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
Table 63. Novelion Therapeutics Main Business
Table 64. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Novelion Therapeutics Latest Developments
Table 66. ProQR Therapeutics Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 67. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
Table 68. ProQR Therapeutics Main Business
Table 69. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. ProQR Therapeutics Latest Developments
Table 71. Spark Therapeutics Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 72. Spark Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
Table 73. Spark Therapeutics Main Business
Table 74. Spark Therapeutics Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Spark Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Leber Congenital Amaurosis (LCA) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Type in 2021
Figure 7. Leber Congenital Amaurosis (LCA) in Hospitals
Figure 8. Global Leber Congenital Amaurosis (LCA) Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Leber Congenital Amaurosis (LCA) in Eye Clinics
Figure 10. Global Leber Congenital Amaurosis (LCA) Market: Eye Clinics (2017-2022) & ($ Millions)
Figure 11. Leber Congenital Amaurosis (LCA) in Medical Research Institute
Figure 12. Global Leber Congenital Amaurosis (LCA) Market: Medical Research Institute (2017-2022) & ($ Millions)
Figure 13. Leber Congenital Amaurosis (LCA) in Other
Figure 14. Global Leber Congenital Amaurosis (LCA) Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Application in 2021
Figure 16. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Player in 2021
Figure 17. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Leber Congenital Amaurosis (LCA) Market Size 2017-2022 ($ Millions)
Figure 19. APAC Leber Congenital Amaurosis (LCA) Market Size 2017-2022 ($ Millions)
Figure 20. Europe Leber Congenital Amaurosis (LCA) Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size 2017-2022 ($ Millions)
Figure 22. Americas Leber Congenital Amaurosis (LCA) Value Market Share by Country in 2021
Figure 23. Americas Leber Congenital Amaurosis (LCA) Consumption Market Share by Type in 2021
Figure 24. Americas Leber Congenital Amaurosis (LCA) Market Size Market Share by Application in 2021
Figure 25. United States Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Region in 2021
Figure 30. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Application in 2021
Figure 31. China Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Country in 2021
Figure 38. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Type in 2021
Figure 39. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Application in 2021
Figure 40. Germany Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Application in 2021
Figure 48. Egypt Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Leber Congenital Amaurosis (LCA) Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 54. APAC Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 55. Europe Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 57. United States Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 58. Canada Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 61. China Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 62. Japan Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 63. Korea Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 65. India Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 66. Australia Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 67. Germany Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 68. France Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 69. UK Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 70. Italy Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 71. Russia Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 72. Spain Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 75. Israel Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Leber Congenital Amaurosis (LCA) Market Size 2023-2028 ($ Millions)